Please assess the completion status of the following clinical trial:

Trial Title: Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Clinical inclusion criteria:~* Age ≥18 years~* Angina pectoris, equivalent symptoms, and/or positive stress test~* Viable myocardium subtended by chronic total occlusion~* Negative pregnancy test in women with childbearing potential~Angiographic inclusion criteria:~* Chronic total occlusion defined as Thrombolysis in Myocardial Infarction flow 0 with an estimated duration ≥3 months~* Successful wire passage and assumption of successful stent/scaffold deployment~* Target reference vessel diameter 2.5 - 4.0 mm~Exclusion Criteria:~Clinical exclusion criteria:~* Limited long-term prognosis with a life-expectancy \<12 months~* Contraindications to antiplatelet therapy~* Known allergy against cobalt chrome, everolimus, or polylactic acid~Angiographic exclusion criteria:~* Target lesion located in the left main trunk~* Target lesion located in a coronary bypass graft~* Bifurcation lesion with planned two-stent strategy~* Indication for coronary artery bypass grafting

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bioresorbable vascular scaffold (Type: EXPERIMENTAL): Implantation of everolimus-eluting bioresorbable vascular scaffold in chronic total occlusion
- Stent (Type: ACTIVE_COMPARATOR): Implantation everolimus-eluting stent in chronic total occlusion

Based on this trial design, predict the completion outcome and termination type (if applicable).